Plasma Biomarkers in Graft-versus-Host Disease: A New Era

Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies

Biomarkers of acute GVHD in the plasma of study and contemporaneous

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

Schematic overview of graft vs. host disease (GVHD) pathophysiology

Megakaryocyte and Platelet Transcriptomics for Discoveries in Human Health and Disease

Plasma Biomarkers in Graft-versus-Host Disease: A New Era? - Biology of Blood and Marrow Transplantation

Biomarkers in acute graft-versus-host disease: new insights - Hrishikesh K. Srinagesh, John E. Levine, James L.M. Ferrara, 2019

Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial - The Lancet Haematology

Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis

Frontiers Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease